Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erdembileg Anuurad

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Indian Journal of Medical Sciences|April 1, 2008
Apolipoprotein E and cardiovascular diseasesErdembileg Anuurad, Lars Berglund
Journal of the American College of Cardiology|July 5, 2008
Role of lipoprotein(a) in cardiovascular disease current and future perspectivesLars Berglund, Erdembileg Anuurad
Metabolic Syndrome and Related Disorders|April 10, 2009
Human immunodeficiency virus and highly active antiretroviral therapy-associated metabolic disorders and risk factors for cardiovascular diseaseErdembileg Anuurad, Alison Semrad, Lars Berglund
Clinical and Translational Science|December 21, 2010
Enigmatic role of lipoprotein(a) in cardiovascular diseaseErdembileg Anuurad, Byambaa Enkhmaa, Lars Berglund
Translational Research : the Journal of Laboratory and Clinical Medicine|April 3, 2016
The unresolved mystery of high-density lipoprotein: time for a paradigm shift?Byambaa Enkhmaa, Erdembileg Anuurad, Lars Berglund
Journal of Lipid Research|December 6, 2015
Lipoprotein (a): impact by ethnicity and environmental and medical conditionsByambaa Enkhmaa, Erdembileg Anuurad, Lars Berglund
Current Opinion in Endocrinology, Diabetes, and Obesity|August 19, 2010
HIV protease inhibitors and obesityErdembileg Anuurad, Andrew Bremer, Lars Berglund
Translational Research : the Journal of Laboratory and Clinical Medicine|February 22, 2015
Mediterranean diet and cardiovascular disease: a step closer to mechanisms using a precision animal model?Byambaa Enkhmaa, Erdembileg Anuurad, Lars Berglund
Current Diabetes Reports|April 29, 2010
Postprandial lipoproteins and cardiovascular disease risk in diabetes mellitusByambaa Enkhmaa, Zeynep Ozturk, Erdembileg Anuurad, et al.
Atherosclerosis|May 27, 2014
Significant associations between lipoprotein(a) and corrected apolipoprotein B-100 levels in African-AmericansByambaa Enkhmaa, Erdembileg Anuurad, Wei Zhang, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Indian Journal of Medical Sciences|April 1, 2008
Apolipoprotein E and cardiovascular diseasesErdembileg Anuurad, Lars Berglund
Journal of the American College of Cardiology|July 5, 2008
Role of lipoprotein(a) in cardiovascular disease current and future perspectivesLars Berglund, Erdembileg Anuurad
Metabolic Syndrome and Related Disorders|April 10, 2009
Human immunodeficiency virus and highly active antiretroviral therapy-associated metabolic disorders and risk factors for cardiovascular diseaseErdembileg Anuurad, Alison Semrad, Lars Berglund
Clinical and Translational Science|December 21, 2010
Enigmatic role of lipoprotein(a) in cardiovascular diseaseErdembileg Anuurad, Byambaa Enkhmaa, Lars Berglund
Translational Research : the Journal of Laboratory and Clinical Medicine|April 3, 2016
The unresolved mystery of high-density lipoprotein: time for a paradigm shift?Byambaa Enkhmaa, Erdembileg Anuurad, Lars Berglund
Journal of Lipid Research|December 6, 2015
Lipoprotein (a): impact by ethnicity and environmental and medical conditionsByambaa Enkhmaa, Erdembileg Anuurad, Lars Berglund
Current Opinion in Endocrinology, Diabetes, and Obesity|August 19, 2010
HIV protease inhibitors and obesityErdembileg Anuurad, Andrew Bremer, Lars Berglund
Translational Research : the Journal of Laboratory and Clinical Medicine|February 22, 2015
Mediterranean diet and cardiovascular disease: a step closer to mechanisms using a precision animal model?Byambaa Enkhmaa, Erdembileg Anuurad, Lars Berglund
Current Diabetes Reports|April 29, 2010
Postprandial lipoproteins and cardiovascular disease risk in diabetes mellitusByambaa Enkhmaa, Zeynep Ozturk, Erdembileg Anuurad, et al.
Atherosclerosis|May 27, 2014
Significant associations between lipoprotein(a) and corrected apolipoprotein B-100 levels in African-AmericansByambaa Enkhmaa, Erdembileg Anuurad, Wei Zhang, et al.
Pageof 6